New Ascites Model for Breast Cancer Research
Author Information
Author(s): F Leonessa, D Green, T Licht, A Wright, K Wingate-Legette, J Lippman, MM Gottesman, R Clarke
Primary Institution: Georgetown University Medical School
Hypothesis
The MDA435/LCC6 ascites model can effectively mimic human breast cancer for drug screening.
Conclusion
The MDA435/LCC6 ascites model closely reflects the drug response patterns seen in untreated breast cancer patients.
Supporting Evidence
- The MDA435/LCC6 cells grow as both malignant ascites and solid tumors in vivo.
- Drug response patterns in the MDA435/LCC6 model reflect those seen in previously untreated breast cancer patients.
- The model has a tumor incidence of approximately 100% in nude mice.
Takeaway
Scientists created a new model of breast cancer using special cells that grow in fluid in the belly, which helps them test new medicines.
Methodology
The study involved creating an ascites model from the MDA-MB-435 breast cancer cell line and testing its response to various cytotoxic drugs in vivo and in vitro.
Limitations
The model may not fully replicate all aspects of human breast cancer due to its specific cell line origin.
Participant Demographics
The parental MDA-MB-435 cells were derived from a 31-year-old Caucasian woman with metastatic breast cancer.
Want to read the original?
Access the complete publication on the publisher's website